Carcinogenesis Advance Access published online on March 19, 2004
Carcinogenesis, doi:10.1093/carcin/bgh152
© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION
1 Department of Pharmaceutical Sciences, School of Pharmacy, University of Colorado Health Sciences Center, Denver, CO 80262, USA
* Corresponding author. E-mail: Rajesh.Agarwal{at}UCHSC.edu.
Received 22 January 2004
; revised 25 February 2004
; accepted 9 March 2004
Nonmelanoma skin cancer (NMSC) accounts for more than one million new cases each year in the US alone suggesting that more approaches are needed for its prevention and control. Earlier studies by us have shown that silymarin (a crude form of biologically active silibinin with some other isomers), isolated from milk thistle, affords strong protection against ultraviolet (UV) radiation-induced NMSC in SKH-1 hairless mice; however, the molecular mechanisms of its efficacy are not known. Here, we assessed the effect of silibinin on UV-induced DNA damage and p53-p21/Cip1 accumulation, and their roles in UV-induced cell proliferation and apoptosis in SKH-1 hairless mouse epidermis. Topical application of silibinin prior to- or immediately after-UV irradiation resulted in a very strong protective effect against UV-induced thymine dimer positive cells in epidermis accounting for 76-85% (P < 0.001) inhibition. In other studies, silibinin treatment resulted in a further up-regulation of p53 by
silibinin, ultraviolet radiation, skin cancer, thymine dimer, apoptosis, p53, p21/Cip1
Silibinin prevents ultraviolet radiation-caused skin damages in SKH-1 hairless mice via a decrease in thymine dimer positive cells and an up-regulation of p53-p21/Cip1 in epidermis
2 Department of Pharmaceutical Sciences, School of Pharmacy, University of Colorado Health Sciences Center, Denver, CO 80262, USA; University of Colorado Cancer Center, University of Colorado Health Sciences Center, Denver, CO 80262, USA
1.6-fold (P < 0.001) together with an increase (2-fold, P < 0.001) in p21/Cip1 protein levels. Proliferative cell nuclear antigen staining showed that silibinin pre- or post-topical application significantly inhibits (40-52 and 20-40%, respectively, P < 0.001) UV-induced epidermal cell proliferation. In addition, silibinin strongly decreased UV-caused TUNEL-positive apoptotic/sunburn cell formation (P < 0.001). These findings suggest that silibinin affords strong protection against UV-induced damage in epidermis by a decrease in thymine dimer positive cells and an up-regulation of p53-p21/Cip1 possibly leading to an inhibition in both cell proliferation and apoptosis. Comparable effects of silibinin following its pre- or post-UV application suggest that mechanisms other than sunscreen effect are operational in silibinin efficacy against UV-caused skin damages.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y.-g. Son, E. H. Kim, J. Y. Kim, S. U. Kim, T. K. Kwon, A-R. Yoon, C.-O. Yun, and K. S. Choi Silibinin Sensitizes Human Glioma Cells to TRAIL-Mediated Apoptosis via DR5 Up-regulation and Down-regulation of c-FLIP and Survivin Cancer Res., September 1, 2007; 67(17): 8274 - 8284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Deep and R. Agarwal Chemopreventive Efficacy of Silymarin in Skin and Prostate Cancer Integr Cancer Ther, June 1, 2007; 6(2): 130 - 145. [Abstract] [PDF]
|
|
|
|
|
|
M. Gu, R. P. Singh, S. Dhanalakshmi, C. Agarwal, and R. Agarwal Silibinin Inhibits Inflammatory and Angiogenic Attributes in Photocarcinogenesis in SKH-1 Hairless Mice Cancer Res., April 1, 2007; 67(7): 3483 - 3491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gu, R. P. Singh, S. Dhanalakshmi, S. Mohan, and R. Agarwal Differential effect of silibinin on E2F transcription factors and associated biological events in chronically UVB-exposed skin versus tumors in SKH-1 hairless mice. Mol. Cancer Ther., August 1, 2006; 5(8): 2121 - 2129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Singh, S. Dhanalakshmi, S. Mohan, C. Agarwal, and R. Agarwal Silibinin inhibits UVB- and epidermal growth factor-induced mitogenic and cell survival signaling involving activator protein-1 and nuclear factor-{kappa}B in mouse epidermal JB6 cells Mol. Cancer Ther., May 1, 2006; 5(5): 1145 - 1153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gu, S. Dhanalakshmi, S. Mohan, R. P. Singh, and R. Agarwal Silibinin inhibits ultraviolet B radiation-induced mitogenic and survival signaling, and associated biological responses in SKH-1 mouse skin Carcinogenesis, August 1, 2005; 26(8): 1404 - 1413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gu, S. Dhanalakshmi, R. P. Singh, and R. Agarwal Dietary Feeding of Silibinin Prevents Early Biomarkers of UVB Radiation-Induced Carcinogenesis in SKH-1 Hairless Mouse Epidermis Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1344 - 1349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Katiyar, A. M. Roy, and M. S. Baliga Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome c release, and caspase activation Mol. Cancer Ther., February 1, 2005; 4(2): 207 - 216. [Abstract] [Full Text] [PDF]
|
|